Navigation Links
SLCH Brings Infertility Specialist to Region
Date:3/12/2008

Mount Sinai-RMA-NY's Dr. Jeff Klein Renowned for IVF Success

NEWBURGH, N.Y., March 12 /PRNewswire/ -- St. Luke's Cornwall Hospital, a clinical affiliate of The Mount Sinai Hospital, is proud to introduce premier fertility care to the Mid-Hudson region with the addition of Reproductive Endocrinologist Jeffrey Klein, M.D. to its medical staff. Dr. Klein serves as medical director of the Westchester division of Reproductive Medicine Associates (RMA) of New York, a fertility center affiliated with Mount Sinai Medical Center. RMA is renowned for its outstanding services and world-class IVF success.

Dr. Klein's areas of expertise include treatment of infertility, IVF, egg donation, endometriosis, polycystic ovarian syndrome, recurrent pregnancy loss, oocyte cryopreservation, and reproductive surgery. Health care research and information company, Castle Connolly, selected Dr. Klein as one of America's Top Doctors in 2007; subsequently, Westchester Magazine recognized him in their "Top Docs" issue. He is a member of the American College of Obstetrics and Gynecology, The American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility.

"We're proud to welcome Dr. Klein, who brings extensive experience and an impressive record of success in the specialty of infertility to our medical staff," said Christine Jelalian, M.D., SLCH Medical Director. "This initiative is another example of SLCH's continued commitment to increase access to physicians in much-needed medical specialties while enhancing facilities, programs and services in our region."

"I'm delighted to bring fertility services to the Mid-Hudson Valley," said Dr. Klein, "and look forward to working with St. Luke's Cornwall Hospital and its physicians in helping individuals and couples achieve their dreams of having a family."

Dr. Klein is board certified in Reproductive Endocrinology and Infertility. He graduated with honors from the
'/>"/>

SOURCE Reproductive Medicine Associates of NY; St. Luke'sCornwall Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dementia diagnosis brings relief, not depression
2. Beyond Vanity: New Treatment Brings Relief to Women After Years of Silent Suffering
3. Accenx Technologies Brings Healthcare IT Solutions to HIMSS08 Interoperability Showcase
4. Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor
5. Elephant Ensemble Theater Brings New Production to Bronx Hospitals
6. Bug guts map brings scientists closer to understanding different bugs role in the body
7. Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data
8. Katherine Heigl Brings Bold and Unabashed Style to Summer Line
9. G&L Guitars Phyllis Fender Brings Smiles to Children Everywhere
10. Queen Latifah Brings in the New Year with a Healthy Resolution
11. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 3Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 4Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 2Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 3Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 2Health News:Kaiser Permanente Gives $5 Million to Children's Healthcare of Atlanta 3
Other Medicine News:Health News:UC San Diego researchers target tumors with tiny 'nanoworms' 2Health News:UC San Diego researchers target tumors with tiny 'nanoworms' 3Health News:Kaiser Permanente's Appointment and Advice Call Center Improves Employee Coaching and Development Activities 2Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 2Health News:CVS Joins Retail Push for Non-Toxic Personal Care Products 3Health News:'The Polyamory Handbook': New Guide Covers Entire Spectrum of Rapidly Growing Relationship Style 2Health News:Smart Balance Announces 2008 First-Quarter Results 2Health News:Smart Balance Announces 2008 First-Quarter Results 3Health News:Smart Balance Announces 2008 First-Quarter Results 4Health News:Smart Balance Announces 2008 First-Quarter Results 5Health News:Smart Balance Announces 2008 First-Quarter Results 6Health News:Smart Balance Announces 2008 First-Quarter Results 7Health News:Smart Balance Announces 2008 First-Quarter Results 8Health News:Smart Balance Announces 2008 First-Quarter Results 9Health News:Smart Balance Announces 2008 First-Quarter Results 10Health News:Smart Balance Announces 2008 First-Quarter Results 11Health News:Smart Balance Announces 2008 First-Quarter Results 12Health News:AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More 2
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 1Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 2Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 3Researchers Uncover Why Turmeric Helps Heal 48078 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 2Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 3